Peptron rises 8.02% amid COVID-19 (Nafamostat) theme uptrend

On the 6th, the COVID-19 (Nafamostat) theme showed strength by rising 3.19% compared to the previous day, while Peptron, a related stock drawing attention, surged 8.02% compared to the previous day. Peptron is known as a bio company specializing in peptide pharmaceuticals.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to provisional data compiled at 14:36, foreign investors have been making large net purchases, buying 13,400 shares of Peptron.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Peptron’s quant financial score is 0.36, which is lower in stability, profitability, and growth compared to the average of other stocks related to COVID-19 (Nafamostat). This can be interpreted as Peptron having relatively low investment attractiveness from a financial perspective compared to other stocks. On the other hand, Chong Kun Dang Holdings ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.